Healthcare Australian Investing Ideas

AU$40
27.8% undervalued intrinsic discount
Fair Value
Revenue
-28.73% p.a.
Profit Margin
27.44%
Future PE
20.03x
Price in 2031
AU$57.4
AU$27
17.6% undervalued intrinsic discount
Fair Value
Revenue
19.81% p.a.
Profit Margin
5.18%
Future PE
19.35x
Price in 2029
AU$33.35
AU$0.76
97.0% undervalued intrinsic discount
Fair Value
Profit Margin
29%
Future PE
118x
Price in 2031
AU$1.13
ANN logo
Ansell

Overweight on ANN

My view: Ansell (ASX: ANN) is a quality, mid-risk company suited for a long-term investment. It operates within a stable and expanding TAM, supported by rising global safety and healthcare demand.Read more

View narrative
AU$34.1
1.7% overvalued intrinsic discount
Fair Value
Revenue
8.95% p.a.
Profit Margin
6.74%
Future PE
22.41x
Price in 2031
AU$50.18
AU$199.7
11.8% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
59.07x
Price in 2031
AU$294.69
AU$196.78
10.5% undervalued intrinsic discount
Fair Value
Revenue
17.32% p.a.
Profit Margin
97.56%
Future PE
57.87x
Price in 2031
AU$288.69
AU$11.11
62.0% undervalued intrinsic discount
Fair Value
Profit Margin
91%
Future PE
48x
Price in 2029
AU$14.79
AU$1.04
69.2% undervalued intrinsic discount
Fair Value
Profit Margin
13.77%
Future PE
31.32x
Price in 2031
AU$3.35